Headline News about Arcellx, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Assessing Arcellx: Insights From 7 Financial Analysts
August 09, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Decoding 8 Analyst Evaluations For Arcellx
July 22, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Arcellx
June 18, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Expert Ratings For Arcellx
May 31, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations For Arcellx's Future
May 14, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Peering Into Arcellx's Recent Short Interest
April 15, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/29/image11.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Ozempic-weight-loss-pill_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Where Arcellx Stands With Analysts
December 11, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](/next-assets/images/schema-image-default.png)
![](https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/12/johnson_controls_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/11/aclx.png?width=1200&height=800&fit=crop)
![](https://barchart-news-media-prod.aws.barchart.com/EXCLSV/0d02574e629de465e51306de4d4fd70c/0kmuvalregzrx8go.png)
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
![](https://www.investors.com/wp-content/uploads/2023/11/IT04-Arcellx-01-news.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/02/aclx.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/02/image39.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.